Multiple Myeloma Specialist

Hear directly from experts who specialize in multiple myeloma.

Multiple myeloma is a cancer that starts in a type of white blood cell called plasma cells. While it is not curable, it is very treatable with a lot of research and clinical trials focused on trying to extend life on the path to a cure.

Explore interviews with medical experts who specialize in multiple myeloma, including oncologists who talk about latest in treatment trends amid a rapidly-shifting landscape that seems to favor new combinations. Also learn more about CAR T cell therapy and bispecifics in multiple myeloma.


James Berenson, MD

Oncologist: Specializing in myeloma and other blood and bone disorders
Experience: 35+ years
Institution: Berenson Cancer Center

Irene Ghobrial, MD

Role: Clinical investigator and professor of hematological oncology
Focus: Multiple myeloma, Waldenström’s Macroglobulinemia, early screening, clinical trials
Provider:Dana-Farber Cancer Institute (Boston)

Nina Shah, MD

Role: Hematologist-oncologist, researcher
Focus: Multiple Myeloma
Institution: University of California, San Francisco (UCSF)

Rafael Fonseca, MD

Role: Interim executive director, hematologist-oncologist
Focus: Multiple myeloma, new drug development
Institution: Mayo Clinic

CAR T Cell Therapy in Myeloma

Dr. Fonseca shares his insights on emerging T-cell therapies for multiple myeloma, describing the role T-cells play in our bodies and then focusing on chimeric antigen receptor (CAR) T-cell therapy and bispecific T-cell engagers.

How Do Clinical Trials Work?

In this episode, Dr. Fonseca details the process of clinical trials, as well as how patients and families can better understand what goes on during each of the main parts of the study.

Joseph Mikhael, MD

Role: Dir. Myeloma Research, CMO at International Myeloma Foundation (IMF)
Focus: Multiple myeloma
Provider: TGen/City of Hope